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Insight into the consequences of the in vivo interaction between antigen and anti- 
body depends on the analysis of systems in which relatively simple chains of reactions 
can be studied. One such system is passive cutaneous anaphylaxis (PCA), an immedi- 
ate type of skin reaction (1, 2), which is initiated by a combination between antigen 
and cell-fixed antibody in the skin and characterized by increased permeability of the 
walls of minute blood vessels in the skin. The first of the events leading to this increase 
in permeability is the attachment of antibody to cells in the intradermally injected 
site of the skin (3-7). The next event is the attachment of antigen to the fixed anti- 
body. After this a  series  of further reactions culminates in increased permeability of 
blood vessels.  The question arises as to what these further reactions arc, and, in par- 
ticular, whether complement is involved in them. So far, most attempts to elucidate 
this question were based on experiments with animals in which the circulating level of 
complement was reduced experimentally.  Such reduction can be caused by systemic 
injection of antigen-antibody precipitates before the injection of the reactants, leading 
to PCA (8-10). Another approach has been based on chemical modifications of antigen 
which result in reduced complement fixation by the complex of antigen and antibody. 
On the basis of such experiments it was concluded that complement is involved in 
PCA of the rat (8, 9), but not of mice (11). 
The role of complement in PCA of the guinea pig was examined by a third type of 
analysis: it is possible to separate antibody into a fraction which fixes complement and 
another which does not. Experiments with such preparations are consistent with the 
view that complement is not involved in PCA of the guinea pig (10). 
There are other cutaneous immunological reactions in which a role of complement 
has been postulated; one of these is the reverse passive Arthus reaction (RPAR), so 
far studied in the rat (12), rabbit (13, 14), guinea pig (7, 10, 15), and mouse (16). The 
R_PAR has been differentiated from PCA by its histopathology, is caused by aggregates 
of antigen and antibody, and does not involve the fixation of antibody to cells (17, 18). 
It is thus characterized by the fact that it can be elicited by antigen,  administered 
simultaneously with the intradermaliy injected antibody. Unlike PCA, R_PAR does 
not depend on the fixation of antibody on cellular sites.  In the context of our present 
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paper only the first stage of RPAR can be studied and will be defined as the perme- 
ability increase which occurs when antigen and antibody are injected simultaneously. 
As has already been indicated, past experiments on the role of complement in the 
various immune cutaneous reactions had to be carried out with animals temporarily 
deprived  of complement.  Such deprivation  was brought about  by the  injection of 
antigen-antibody complexes,  of aggregated gamma globulin  (19,  20),  or of  various 
chemical reagents (21). The biological  effect of such agents is, however, not confined 
to the complement system but extends to various cellular elements (22).  It is, there- 
fore, always questionable whether changes in the reactivity of the experimental animal 
are attributable to one or all of several biological effects of the pretreatment. It would 
therefore be of value to investigate the effect of complement with animals which are 
genetically deficient in complement. Complement-deficient guinea pigs (23) and com- 
plement-deficient rabbits  (24)  have been described,  but these animals could not be 
produced in sufficient  numbers to allow extensive experimentation. Recently, it has, 
however, become evident that whereas some strains of mice possess  a complete com- 
plement system (25),  other strains of inbred mice lack one factor of the complement 
system (26-28). The discovery of an antibody by which an antigen, MuB1, can be 
detected has allowed us to demonstrate that the absence of this antigen can be corre- 
lated  with  a  hemolytically non-functional  complement  system  (28-31).  This  has 
facilitated an extensive survey of inbred strains of mice for the presence or absence of 
a hemolyticaUy functional complement system, and thus it has been possible to classify 
inbred strains as complement-positive or complement-negative (30, 31). On the basis 
of this information the role of complement can be investigated in a variety of patho- 
logical conditions caused by antigen-antibody interaction. 
The PCA reaction can be demonstrated in mice.  Ovary (32) who used egg albumin 
and egg albumin antibody (rabbit),  found that the reaction could be detected with 
0.4 to 0.5 Izg N antibody and that the optimal interval between the intradermal injec- 
tion of antibody and the intravenous injection of antigen was 3 hours. 
It is the purpose of the following experiments to investigate the role played 
by complement in passive cutaneous reactions (PCA)  of mice which have been 
shown to possess the antigen MuB1 and of mice which have been shown to lack 
this antigen. 
The reactants chosen for the following study were crystalline bovine ribonu- 
clease and the antibody to this antigen, raised in rabbits. Ribonuclease has been 
previously shown to be able to elicit PCA (9), and its choice in our experiments 
was motivated by the extensive information available in our laboratory on the 
interaction between ribonuclease and the corresponding antibody (33, 34). 
Materials and Methods 
Materials.- 
Mice: Of the 18 strains  of inbred mice used, 17 were obtained  from Roscoe B. Jackson 
Memorial Laboratories, Bar Harbor.  Strain SL/R1 was obtained from Dr. Liane B. Russell, 
Biology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee. Non-inbred strains 
of Swiss mice, all MuBl-positive,  were obtained from the Connaught Institute, Toronto. The S.  BEN-EFRAIM  AND  B.  CINADER  927 
following MuBl-positive mice were employed  (29): BALB/cJ,  BDP/J,  BUB/Bn, CBA/J, 
C57BL/6J, C57BR/cdJ, C57L/J, C58/J, PL/J, SJL/J,  SL/R1,  129/J, Swiss.  The following 
MuBl-negative  mice  were  employed  (28):  A/HeJ,  AKR/J,  CE/J,  DBA/2DeJ,  RF/J, 
SWR/J. 
Guinea pigs: Animals of Hartley strain were obtained from Mr. Fred Geissen, New York. 
Normal rabbit sera (NRS): Sera were obtained by separation from the pooled blood of 15 
to 20 normal adult rabbits, bled from the carotid artery. Before use,  the rabbit sera were 
kept  for  1  hour  at  56°C. 
Normal guinea pig sera (NGPS): Blood was obtained by cardiac puncture of inbred guinea 
pigs (Hartley strain). Sera were separated and used on the day on which the blood was ob- 
tained. Blood and sera were kept at +2°C from the moment the blood was shed to the time 
the sera were used. 
Ribonudease antiserum: Rabbits were immunized by subcutaneous injection with bovine 
pancreatic ribonuclease incorporated in Freund's adjuvant; followed by a  course of intra- 
venous injections as  described previously  (29).  The serum  used in these experiments was 
801  (13/2/63). It contained 1.0 nag of antibody N/ml. 
Ribonudease: Bovine pancreatic ribonuclease was obtained from Sigma Chemical Co., St. 
Louis (crystallized 5 times) Lot 6 3B-1020. Activity, 43 Kunitz units/rag. 
Diluent: Reactants were diluted with 0.15 u  sodium chloride. 
Dye: Evans blue was obtained from Fisher Scientific Company. The dye (1 per cent w/v) 
was diluted in 0.15 ~  sodium chloride. 
Methods.- 
Quantitative predpitin test: The antibody content of ribonuclease antiserum 801  was de- 
termined by quantitative nitrogen assay of antigen-antibody precipitates (29). 
Bleeding of mice: Mice were bled from the tail. The animals were placed in plastic tubes 
which bad an air hole punched in the normally closed part of the tube. At the opposite end, 
the tube was closed with a neoprene stopper. This stopper had a central hole, through which 
the tail of the mouse was threaded. The tail was then immersed in warm water, dried with 
filter paper, and the end was snipped off. 
A test tube (height, 50 mm; diameter, 9 mm) surrounded by an ice-water bath was placed 
in a conical flask which was evacuated. Blood was shed into the test tube. The tubes containing 
blood were kept in an ice-water bath for about 1 hour and were then centrifuged at 0-2°C. 
The serum was then separated and was centrifuged again until free of erythrocytes. Sera were 
used  immediately after separation. 
Intradermal injections: The backs of mice were shaved with an electric hair clipper (Oster 
model A2-22 small). The total volume injected into any one skin site was 0.025 mi. One in- 
jection was administered on each side of the animal with syringes of a  capacity of 0.25 ml 
fitted with needles ~  inch in length and 27 gauge in width. 
Intravenous injections: Ribonuclease and Evans blue were mixed immediately before the 
injection (final concentration of Evans blue was 0.5 per cent w/v). 0.25 ml of this mixture 
containing 100 #g N  of ribonuclease was injected into the tail vein of each mouse (needle: 27 
gauge, a/~ inch in length). 
Test for presence  ofMuBl: Sera were tested for the presence or absence of antigen by double 
diffusion in agar against a rabbit serum or mouse serum specific for MuB1 (28). 
Test for passive cutaneous anaphylaxis  (PCA):  Intradermal injections with ribonuclease 
antibody were followed 2.5 to 3.0 hours later, if not otherwise stated, by intravenous injection 
of a mixture of Evans blue and ribonuclease. In some experiments the mixture of ribonuclease 
and Evans blue was injected first and the intradermal injection of antibody was administered 
immediately afterwards. In all e:~periments the antigen quantity administered was 100 #g N 
ribonuclease.  1 hour after the intravenous injection the mice were sacrificed. The skin was 928  ROLE  OF  COMPLEMENT  IN  THE  PASSIVE  CUTANEOUS  REACTION 
removed and the diameter of the blue area on the inner surface of the skin was recorded as the 
mean of two measurements  at right angles. 
Test of the effect of intravenously administered serum on the reaction of PCA: Sera from normal 
animals were mixed with ribonuclease  and Evans blue immediately before  intravenous  in- 
jection. Intravenous injections  and other technical procedures  were carried out as described 
above. 
RESULTS 
The  intradermal injection of ribonuclease antiserum followed by the intra- 
venous  injection of a  mixture  of ribonuclease and  Evans  blue led to  the ap- 
TABLE  I 
PCA Response in  Various Strains  of Mice 
All animals were males, 6 weeks of age. Intravenous injection:  100 #g N  ribonuclease. 
Strain 
BALB/cJ 
8UB/Bn 
SJL/J 
Swiss 
~verage .... 
gHe/J 
~KR/J 
~F/J 
~WR/J 
~verage .... 
MuB1 
+ 
+ 
+ 
+ 
+ 
h 
D 
m 
1 
mm 
0.6  (12) 
Average diameter of response 
Ribonuclease antibody injected  intradermally, gg 
N antibody per skin site 
2.5 
mm 
0.8  (9) 
0.8  (9) 
3 
ram 
5.8  (5) 
5.5  (6) 
8.8  (11) 
4.9  (10) 
6.2  (32) 
0.5  (10) 
0.5  (7) 
D  (4) 
~.5  (5) 
I0.25  (21) 
6  12.5 
mm  mm 
8.8  (3)  8  (3) 
5.8  (6)  8.7  (4) 
10.4  (9)  11.2  (9) 
6.2  (12)  7.9  (6) 
7.8  (30)  8.9  (22) 
1.9  (8)  6.7  (5) 
1.9  (7)  6.4  (7) 
1.2  (4)  5.7  (4) 
2.0  (5)  6.8  (3) 
1.7  (24)  6.4  (21) 
25 
mm 
11.5  (2) 
10.0  (2) 
12.8 
10.1 
11.1 
11.9 
9.5 
8.7 
10.0 
NRS per 
skin site 
0  (2) 
0  (2) 
(8)  0  (8) 
(27)  0  (21) 
(39)  0  (33) 
(6)  0  (7) 
(5)  0  (2) 
(2)  0  (2) 
(2)  0  (2) 
10.0  (15)  0  (13) 
The figures in parentheses indicate the number of mice used for each determination. 
pearance of a blue area which could be readily seen and measured on the under 
side of the skin. The size of the blue area increased as a function of the quantity 
of antiserum injected into the skin.  With large doses of antibody  (25  #g N), 
lesions reaching 11 to 13 mm could be observed both in animals which did, and 
did not, possess MuB1. However, if smaller doses of antibody were injected, a 
difference between  the  sizes  of lesions of negative  and  positive animals  was 
discernible. This difference increased if the amount of antibody injected intra- 
dermally was decreased. At low doses of antibody, animals lacking MuB1  did 
not show lesions, whereas animals possessing MuB1 showed lesions of a diameter 
of about 5 mm (Table I, Fig. 1). It was thus possible to establish a  correlation 12 
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FIG. 1. A comparison of the reactivity of MuBl-positive  and MuBl-negative mice; relation 
between the size of the "blued" area and the amount of antibody injected intradermally.  , 
response of MuBl-positive  mice (all included in cross-hatched area);---, response of MuB1- 
negative mice (all included in dotted area). 
Male  mice  (6 weeks old): 
O, Swiss (Connaught)  (I) 
e, BALB/cJ (2) 
0, Bu~/~n (3) 
~, SJL/J (4) 
I-1, AHe/J (5) 
I  AKR/J (6) 
A, RF/J (7) 
A, SWR/J (8) 
between the presence and absence of MuB1 and the absence or presence of a 
blued area when 3 gg N  antibody was injected intradermally and by the size 
of the blued area if 6 gg N  antibody was injected intradermaUy. The question 
now arose whether  the permeability  of MuBl-negative  animals  would be af- 930  ROLE  OF  COMPLEMENT  IN  THE  PASSIVE  CUTANEOUS  REACTION 
fected if they were supplied with serum from MuBl-positive animals. MuB1- 
negative animals were injected intradermally with antibody (3  /~g N)  and 3 
hours later with  a  mixture of antigen,  Evans blue,  and  serum  from MuB1- 
positive animals. Under these conditions, "blued" areas were observed. Blued 
areas did not appear if serum from animals lacking MuB1 was injected intra- 
venously (Table II). 
We have thus demonstrated that a humoral factor is involved in the increase 
of permeability at low doses of intradermally injected antibody. 
So far, we had only been able to experiment with white mice. On the basis 
of the last mentioned experiment, it was possible to demonstrate presence or 
absence of MuB1  in  dark skinned  animals  in  which  tests based  on a  direct 
reading of skin lesions would be difficult. 
It will be seen from Table III that the serum obtained from eleven different 
strains which were MuBl-positive led to the appearance of positive PCA reac- 
tions in normally non-reactive AKR/J mice and that injection of the serum of 
MuBl-negative strains would not lead to any demonstrable increase in permea- 
bility. 
We investigated whether the humoral factor could be supplied by sera other 
than those of mice and in particular, by those of guinea pigs. MuBl-negative 
mice  (AKR/J)  received intradermal  injections of antibody  (6  #g  N)  and  3 
hours later intravenous injections of Evans blue, antigen, and various quantities 
of fresh, normal sera.  The size  of the  blued area depended on  the  quantity 
and source of the fresh normal sera. Sera from guinea pigs were more effective 
than those of mice under the  conditions of our experiment. Guinea pig sera 
were approximately 5 times as effective as those of Swiss mice (Table IV, Fig. 
2). 
We have so far shown that there is a considerable difference in the extent of 
the lesions occurring in PCA in animals possessing MuB1 and in animals lack- 
ing  this  antigen;  an  MuBl-negative  animal  can react like a  MuBl-positive 
animal  if  supplied  with  a  sufficient  quantity  of  MuBl-positive  serum  and 
the humoral factor responsible can be supplied with guinea pig serum as well 
as with mouse serum. 
Having  established  the  involvement of a  humoral  factor  in  permeability 
changes,  caused  by antigen-antibody  complexes, we  turned  to  the  problem 
posed by the marked change in the differences of the blued area of positive and 
negative animals as a function of the quantity of intradermally injected anti- 
serum. This difference is very small if relatively high doses of antiserum are 
injected (Fig. 1). 
It seemed possible that the heat-treated antiserum contained a  heat-stable 
component, other than antibody, which affected permeability. At high doses, 
but not at low doses of antibody, enough of this substance might be injected to 
affect permeability  profoundly. To  test  this  assumption,  the  effects of  low TABLE II 
The Effect of Intravenously Injected Fresh Serum  on PCA  Reactions in MuB1-Negative  Mixe 
(AKR/Y Male, 6 Weeks Old) 
Sourc~ of serum 
Strain  MuBI  Sex 
A/HeJ 
AKR/J 
BALB/cJ  + 
CBA/J  + 
CE/J 
C57BR/cdJ  + 
C57L/J  + 
C58/J  + 
DBA/2DeJ  -- 
MA/J  + 
PL/J  + 
RF/~ 
Swiss 
SWR/J 
SL/RI 
129/J 
C57BL/6J 
+ 
+ 
+ 
+ 
C 
C 
9 
9 
{: 
c~ 
{(Po~l) C 
C 
C 
<: 
C 
Amount of 
serum injected 
intravenously 
O. 125 
0.089 
O. 089 
O. 125 
0.052 
O. 125 
0.025 
0.025 
0.125 
O. 125 
0.025 
0.025 
0.025 
O. 025 
0.025 
O. 052 
0.025 
O. 025 
O. 125 
O. 125 
O. 125 
O. 025 
O. 125 
0.073 
0.059 
0.025 
0.073 
0.125 
0.025 
Diameter as a function of #g N 
sntlbody injected 
3 ,ugN 
mm 
0  0 
0  0 
0  0 
0  0 
0  0 
O, 0  O, 0 
10, 10.5  11, 13.5 
6, 9.5  9, 11.5 
0  0 
6.5, 5  10, 8.5 
12  14 
8  10.5 
5, 6  8.5, 9.5 
4  8 
6  6 
0  0 
4  10 
10  13.5 
0  0 
0  0 
O*  O* 
o~  o~ 
7.5  16 
0  0 
0  0 
0  0 
5  5.5 
4.5  4 
6  7.5 
10, 11, 12.5 
6ggN 
12.5, 15, 18.5 
* 6 determinations. 
$ 8 determinations. 
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quantities of intradermaUy injected antibody were compared when the antibody 
was diluted with 0.15 x~ NaC1 and when it was diluted with normal heat-treated 
(56°C,  1 hour) rabbit serum. It was found (Table V) that the presence of nor- 
mal heat-treated antiserum did not affect the size of the blued area. We there- 
fore could eliminate the possibility that a  substance in heated rabbit serum, 
other  than  antibody,  contributed  to  the  blueing.  We  considered next,  the 
possibility that two types of independent reactions occurred of which one did 
not involve the complete hemolytic complement system. To investigate this 
possibility we examined the size of the blued area when antigen was injected 
TABLE HI 
Summary  of the Effect o/Fresk Serum  on PCA Reactions in MuB1-Negative Inbred Strain 
AKR/J Male, 6 Weeks Old 
Total No. of 
straia~ 
II 
Saline, O. 15 z~ 
NaCI 
Total No. 
of sera  MuB1 
21  + 
14 
Antibody 
injected 
ug N 
3 
6 
PCA reactions 
~nt  Present  r,  Mean diameter 
mra 
{o 
0.5 
1.9 
intravenously before the injection of antibody, in other words, when there was 
no "latent" period and under conditions which according to Fischel and Kabat 
(13),  Levy (16),  and Benedict and Tips  (35),  result in the passive reversed 
Arthus reaction. Under these conditions no difference was found in the size of 
lesion elicited in animals possessing, and in animals lacking, MuB1, as can be 
seen from the data presented in Table VI. 
Thus, if antigen and antibody were injected at the same time there was no 
difference in the size of the blued area of MuBl-positive and negative mice. On 
the other hand, a marked difference between the blued areas of these two types 
of animals was observed when antigen was given 3 hours after the injection of 
antibody. It therefore seemed that permeability changes occurring when antigen 
and antibody were injected simultaneously did not require the complete hemo- 
lytic complement system, whereas  the  permeability changes occurring after 
antibody had been in the skin tissue for 3 hours depended on the presence of 
the  complete hemolytic complement system. To  study this  further,  we  de- S.  BEN-EFRAIM AND B.  CINADER  933 
TABLE IV 
Effect  oJ Intrarenous  Administration  of Varying  Amounts  of MuB1-Positive  Serum  on  the 
Extent of PCA Reaction in MuB1-Negatire  Mice 
Strain AKR/J male; amount of antibody injected:  6/~g N. 
Source of serum  PCA reaction, diameter 
Amount of  Average of 
Species  Strain  serum injected  Individual measurements  all measure- 
intrsvenouJly  manta 
Nlouse 
~uinea pig 
Swiss 
Swiss, heated 
560C, 20 
C57BR/cdJ 
Hartley, inbred 
0.125 
0.025 
0.005 
0.001 
0.0007 
0.0005 
0.00025 
O. 125 
O. 125 
0.042 
0.125 
0.05 
0.025 
0.0125 
0.0062 
0.025 
0.005 
0.001 
0.0005 
0.00035 
0.00025 
mm 
9, 21, 8.5, I1, 10.5,  13 
9, 12, 16, 9.2, 9, 7.5, 7 
6.5, 8.5, 4, 5.5, 5.5 
5.5, 6, 5, 4, 3 
3.5, 2.5, 4.5, 3.7, 3, 0, 0, 0 
O, O, O, 3.7 
0, 0, 0, 3.5 
0, 0, 0, 5.5, 7, 3.5 
10, 8.5 
4, 8 
10.5 
7 
7, 10.5 
0, 0 
0, 0 
Generalized reaction 
15, 12, 13, 10.5 
9, 6.5, 7.5, 7.5, 8, 7 
9, 7.5, 8, 7.5 
7.5, 6, 7.5, 5, 5 
0, 0, 7, 7.5, 8, 7, 6.5, 5 
12.2 
12.0 
7.5 
4.7 
2.2 
0.9 
0.9 
2.7 
9.2 
6.0 
8.80 
oo 
12.6 
7.5 
8.0 
6.2 
5.1 
2ontrol  Saline  0, 3.5, 0, 0, 4.5, 5, 0  1.9 
termined the size of the blued area as a  function of the time elapsing between 
intradermal injection of 3 #g N  antibody and intravenous injection of antigen. 
This was tested in AKR/J mice which lack the antigen MuB1 and with MuB1- 
positive  Swiss mice.  In MuBl-negative  mice,  the  size  of the  blued  area was 
greatest when intradermal and cutaneous injections were given simultaneously, 
was small when the interval between injections was increased beyond 30 min- 
utes, and could not be observed with an interval of 1 hour (Table VII). In the 
MuBl-positive  animals, on the other hand,  the blued area was still very large 934  ROLE  OF  COMPLEMENT  IN  THE  PASSIVE  CUTANEOUS  REACTION 
if  the  interval  between  injections  was  3  hours  and  remained  detectable  for 
intervals of up to 6 hours. 
The question now arose whether the length of time for which this first reac- 
o 
q) 
J 
OJ 
O.OI 
0.001- 
0  Guinea  pig  A 
A  Swiss 
2  4  6  8  10  12 
Size  of "blued"areo (in mm) 
FIG. 2. The relation between the size of the blued area and the quantity of fresh, normal 
sera injected into MuBl-negative mice (AKR/J). O, guinea pig sara; A, sera from MuB1- 
positive Swiss mice. 
TABLE V 
Effect of Serum Diluent on PCA Reaction  at Low Concentration  of Antibody 
Strain AKR/J male, 6 weeks old; ribonuelease serum 801 injected intxadermally: 3 #g N 
antibody; NRS: normal rabbit serum inactivated  (56°C, 1 hour).  (Same pool as used in NRS 
controls  injected  intradermally.)  Ribonuelease  antigen  in  saline. 
Strain  Serum 801  diluted in  Diameter  Mean diameter 
gf~  mm 
AKR/J  NRS  0, 0, 0, 0, 0, 0, 0, 4  0.5 
0.15 g NaC1  0, 0, 0, 0, 0, 0, 3.5  0.5 
801 dilution: 0.1 ml; 801S 1.0 mg N antibody/mL 0.7 ml; diluent  (NRS or 0.15). 
tion, not requiring hemolytic complement,  can be observed,  depended  on the 
quantity of antibody injected intradermally. 
To investigate  this possibility,  we examined the size of the blued  area as a 
function of the time elapsing between intradermal injection of 25 #g N  antibody 
and  intravenous  injection  of antigen.  This  was  tested  in AKR/J  mice which 
lack the antigen MuB1  and in Swiss mice which possess MuB1. S. BEN-EZRA]~[ AND  B. CINADER  935 
At high doses of antibody the size of the blued area underwent little change 
if the interval between injections was increased from 0  to 10 hours. If the in- 
terval was further increased a  marked difference in the blued area of MuB1- 
positive and negative animals was observed and at  15  hours no permeability 
TABLE VI 
Size of the Blued  Area when  Intravenous  Ribonuelease  Injection  Preceded 
Intradermal  Antibody Injection 
[[~ Strain  MuBI  Serum  Concentration 
AKR/J  --  NRS 
SJL/J  +  NRS 
801RnS 
801RnS 
Undfl. 
1/20 
1/80 
Undfl.* 
2.5  #g N antibody 
1.25 #g N antibody 
0.6  #g N antibody 
0.3  ggNantibody 
0.159gNantibody 
Undfl. 
1/2o 
1/8o 
Undil.* 
2.5  #g N antibody 
1.25 #g N antibody 
0.6  ~tg N antibody 
0.3  #g N antibody 
0.15 #g N antibody 
Swiss  -4-  NRS  Undil. 
801 RnS  25/~g N antibody 
Diameter of the reaction, 
individual  measurements 
firm 
0, 0, 0, 0, 0, 0 
0, 0 
0, 0 
12.5, 12.5, 10.5,  11 
6.5, 7 
7.5 
4, 5, 6 
0, 0 
0, 0, 0, 0 
o, o, o, o, o, o 
o, o 
o,o,o 
10.5,  10, 10, 11 
6, 6.5 
6.5, 8.25 
4, 6, 7, 5.5 
0, 0 
0, 0 
0, 0, 0, 0 
9, 9. 5, 8. 25, 9.25 
Mean 
diameter 
m~'t 
0 
0 
0 
11.6 
6.7 
7.5 
5 
0 
0 
10.4 
6.25 
7.3 
5.6 
0 
0 
Conditions of the experiment: Intravenous injection of Rnase in Evans blue (0.25 ml). 
Final concentration of ribonuclease:  100 ~tg N; final concentration of  Evans blue: 0.5 per 
cent. Immediately after intravenous injection, intradermal injection of serum dilutions (0.025 
ml). Reading: inner side, 1 hour after intradermal injection. 
"25 ttg N. 
increase  could be  seen  in MuBl-negative  animals.  At the  same  interval  the 
blued area of MuBl-positive animals was still 70 per cent of that obtained when 
injections were given simultaneously. As the interval was increased beyond 15 
hours the size of the blued area decreased but was still demonstrable after 24 
hours. 936  ROLE  OF  COMPLEMENT  IN  l'tiv:  PASSIVE  CUTANEOUS  REACTION 
TABLE  VII 
Si~e of tl~ Blue~ Area as a Funaion of the Time between Intrad~mal Injection of Antibody and 
Intravenous  Injection of Anggen  (Latent Per~d) 
Strain males  MuB1  Latent  period 
3 #tg N antibody 
,tin.  tara 
AKR/J  --  0  5.5,  7,  5.75,  5.5,  7.5,  6,  (6.0) 
5.5, 6, 5.5, 6 
0.5-1  5.25,  5.5,  5.5,  5.25,  5.5,  (5.5) 
5.25, 4.75, 6.5, 6, 5.5 
30  5.25,  5.25,  O,  5.5,  5.25,  (5.0) 
5.5, 6.75, 6.5, 4, 6.25 
45  4.5, 5.5, 7.5, 7.5, 5.25, 4.5,  (5.3) 
3.5, 3.5 
60  3.5, 3, 4.75, 5, 4, 2, 2.5,  (2.8) 
0,0 
90  2,0,0,0,4,4.25,0,0,  0,2  (1.2) 
120  0, 0, 0, 0, 0, 0, 0, 0, 0, 0  (0.0) 
180  O, O, O, 3.5, 4.5, 5  (2.1 
600 
915 
11440 
BALB/cJ  +  180  4, 6, 5, 7, 7  (5.8) 
1200 
Swiss  +  0  5.75, 6, 8.5, 7, 6, 6, 0, 4.5,  (5.7) 
5.25, 6, 6. 5, 7 
5.5,6.5, 7.5, 7.75,3.5,6,4,  (5.6) 
4.25, 4.75, 5.5, 6, 5.75 
90  5, 5.25,  6.5, 6, 5.5, 4.5, 0,  (4.6) 
4, 5.25, 4, 4.5, 4.75 
180  6.5,  5,  3.75,  4.75,  4,  5,  (4.8) 
5.75, 5.5, 5.25, 3.25 
225  0, 0, 3.5, 6.5, 0, 0, 3.5, 3,  (3.6) 
10, 6.5, 5, 5.5 
270  4, 5, 0, 0, 4.5, 5.5, 5.75, 6,  (3.3) 
4.5, 4, 0, 0 
360  0,0,0,0,0,0,5.75,4.5,0,  (1.2) 
0, 0, 4.25 
420  0, 0, 0, 0, 0, 0, 0, 0, 0, 0,  (0.0) 
0, 0 
600 
915 
1440 
Mean diameter as a function of ~g N  antibody injected intradermally 
25 #g N antibody 
ram 
12.5, 12.5, 10.5, 11  (11.6) 
7.5, 7.5  (7.5) 
10, 9  (9.5) 
9, 9.5  (9.3 
6, 6  (6.0) 
7.25, 6.5  (6.4) 
7, 6.5  (6.8) 
9, 8, 8.5, 11.5, 10.5  (9.5 
8,6,6,8,5,6,8,6  (6.6) 
0,0,0,0,0,0,2,2  (0.5) 
0,0,0,0,0,0,2,2  (0.5) 
12, 11  (11.5) 
6,4.5,5.5,4,5,7  (5.3) 
9, 9.5, 8.25, 9.25  (9.0) 
9.5,  10,  11.5,  8.5,  (10.1) 
11 
11.5,  11.5,  10, 10  (10.8) 
5.75,  6, 9.5,  10.25,  (8.4) 
8, 8, 10, 10 
O, O, O, O, O, 5,  5,  (1.9) 
5.5 
Numbers in parentheses are the means of all determinations. S.  BEN-EFRAIM AND  B.  CINADER  937 
It would thus seem reasonable  to conclude that two different reactions  are 
involved in permeability increase. The first reaction,  occurring  when antigen 
and  antibody  are  injected  simultaneously, does  not  require  the  complete 
TABLE VIII 
The Effect of Fresh Serum on PCA in MuB1-Negative Mixe (AKR/J Male, 6 Weeks Old) when 
the Interval between Intradermal Injection of Antibody and 
Intravenous Injection of Antigen Was 15 Hours 
Source of serum 
Strain 
Swiss 
AXR/J 
0.15 ~  NaC1 
MuBI 
+ 
m 
1 
12 
Z 
--II 
"'  9 
..1 
~  a- 
n.-  7- 
I,I 
I--  6-  b..l 
~  4- 
Z 
hA 
I 
Amount of Serum injected 
intravenously 
m/ 
O. 125 
O. 125 
Diameter, 25 ~g N antibody 
injected  intradermally 
H 
8, 7, 6.5,  7, 6.5 
0, 0, 0, 0, 0, 0 
0, 0, 0, 0, 0, 0, 2, 2 
o 
4-  6  8  IO 12  14. 16  18 2'0 2'2 ~4 
TIME  IN  HOURS 
FIo. 3.  The effect of the interval between the intradermal injection of antibody and the 
intravenous injection of antigen on the size of the blued area. A comparison between MuB1- 
negative and MuBl-positive animals. 
/~nlmals were injected intradermally with 25 #g N  antibody and at various periods there- 
after were given intravenous injections of the antigen. The arrow indicates the change in the 
diameter of the blued area when MuBl-negative animals were injected with fresh normal 
serum of MuBl-posltive mice. 
Size of blued  area  in:  l,  Swiss  (MuBl-posltive); V,  BALB/cJ  (MuBl-positive);  O, 
AKR/J (Mu.Bl-negative); 0, AKR/J when serum from MuBl-positive Swiss mice is injected 
intravenously at the same time as the antigen. 
hemolytic complement system. The reaction occurring when antigen is injected 
some time after the antibody requires the complete hemolytic complement sys- 
tem. The interval for which  the first of these  two reactions  is demonstrable 
depends on the quantity of antibody injected. If MuBl-negative animals were 
injected with 3 #g N antibody, the contribution of the first reaction was negli- 938  ROLE  OF  COMPLEMENT  IN  THE  PASSIVE  CUTANEOUS  REACTION 
gible 3 hours after the injection of the antibody, but was still very marked 
when 25 #g N antibodv had been given. 
The difference between the reaction of MuBl-positive and MuBl-negafive 
animals  appeared  to  be  attributable  to  a  hemolytic complement-requiring 
second reaction which did not occur in MuBl-negative animals. If this con- 
clusion is correct, it should be possible to produce a blued area in MuBl-nega- 
tive animals even 15 hours after the injection of 25/zg N antibody by providing 
the humoral factor required by the second reaction. 
To test this latter conclusion, MuBl-negative animals were injected intra- 
dermaily with 25/zg N of antibody and were injected 15 hours later with antigen 
mixed with fresh serum from MuBl-positive mice. The MuBl-negative ani- 
mals, so injected, showed a  blued area, comparable in size to that of MuB1- 
positive mice, injected under similar conditions, but not given additional mouse 
serum. If MuBl-negative mice were injected with sera from MuBl-negative 
animals, a blued area did not appear (Table VIII, Fig. 3). Thus, if large doses 
of antibody are given to complement-deficient  mice, a blued area is not observed 
if antigen is given 15 hours later, unless a  missing complement factor is sup- 
plied. 
DISCUSSION 
The detailed analysis of in vivo reactions is aided by the availability of ex- 
perimental animals which differ in molecularly defined factors. The availability 
of complement-deficient mice offers new possibilities in this respect and we have 
utilized such animals in the investigation of the early stages of immunological 
injury. 
Two phases  in  the permeability reaction of the mouse are  demonstrable; 
the first of these reaches its peak shortly after the injection of antigen and does 
not  require  the  complete  hemolytic complement system. The  second,  later 
phase, requires the complete hemolytic complement system since it does not 
occur in MuBl-negative mice. 
The duration of the two phases, but not their relative difference, depends on 
the quantity of antibody injected, so that an interval can be found for small or 
large doses, at which MuBl-positive animals show blueing, and MuBl-negative 
animals do not respond. If very large doges of antibody are injected (25/zg N), 
the same two phases were observed but their duration was greatly increased. 
The first phase became negligible only after 15 hours. If, after this interval, 
normal serum from MuBl-positive animals is administered to MuBl-negative 
animals, a  lesion develops and differs little in size from the lesions of MuB1- 
positive anlmais. It would, therefore, seem justified to conclude that a humoral 
factor is involved. Since this humoral factor can, in the second of the two phases, 
be supplied with the serum of MuBl-positive but not with that of MuBl-nega- 
tire mice (29, 31),  it is reasonable to conclude that the humoral factor is con- 
nected with the complete hemolytic complement system. S.  BEN-EFRAIM  AND  B.  CINADER  939 
What mechanism mediates the permeability increase in the first phase of the 
permeability reaction,  the  only one seen in  MuBl-negative  animals,  is  not 
clear.  Such animals,  while lacking one component of complement, which may 
be C'3 and possibly C~3d (28, 36), still seem to possess most of the other com- 
ponents of complement. Whether this incomplete complement system can bring 
about permeability increase  or whether an alternative system operates in the 
blueing reaction of MuBl-negative mice must remain an open question. 
The differences  in  the complement system of MuBl-negative and  MuB1- 
positive mice,  alone,  cannot  explain  the difference in the cutaneous reaction 
of the two types of mice. Heterogeneity in the interaction between complement 
and antibody must also be involved. The first of the two reaction phases cannot 
involve all antibody molecules,  interacting  with two different systems which 
both promote permeability increase,  since this would result in marked differ- 
ences in the cutaneous response of i~uBl-positive and MuBl-negative animals, 
irrespective of the interval between injections. However, the permeability in- 
crease,  observed in MuBl-negative and MuBl-positive mice, was similar  and 
seemed independent of the presence or absence of the hemolytic complement 
system, if antigen was injected prior to antibody (Table VI). 
The two phases in the cutaneous response of the mouse may be the result of a 
heterogeneity of the antibody such as that described in guinea pigs (7, i0). An 
immune serum may contain two, and possibly several fractions of antibody, 
which may differ in the rate at which they fix to tissues, combine with antigen, 
and fix complement. A fraction of antibody which fixes rapidly to tissues and 
affects permeability through some such component as C'1 or through a system 
other than complement, may cause the first of the two phases observed in the 
cutaneous response of the mouse. A fraction of antibody which fixes slowly to 
tissue and involves activation of one of the terminal factors of the hemolytic 
complement system, may be responsible  for the second phase of the blueing 
reaction. 
An alternative explanation of the two observed phases of the cutaneous re- 
action, also possibly connected with heterogeneity of antibody, would attribute 
the two phases of the cutaneous response to the effect of antigen-antibody com- 
plexes not fixed to cells, on the one hand, and of cell-fixed complexes,  on the 
other hand. Antigen-antibody complexes, not fixed to tissue, lead to increased 
permeability. If such complexes persisted for a sufficiently long time, they might 
contribute to the increase  in permeability, resulting from the combination of 
antigen with fixed antibody. Thus two reactions would occur simultaneously; 
the first, due to unfixed antigen-antibody complexes, possibly corresponding  to 
the initial stages of the RPA reaction, would be most intense shortly after the 
intradermal  injection of antibody and  would decrease as a  function  of  time 
elapsed after the intradermal injection of antibody. The second, the reaction of 
PCA, would, at first,  increase  with time elapsed after intracutaneous injection 
of antibody and would subsequently decrease. 940  ROLE  O~"  COMPLEMENT  IN  THE  PASSIVE  CUTANEOUS  REACTION 
At present, a decision between the above alternatives cannot be made, the 
nature of the antibody heterogeneity remains to be explored and only the study 
of different antibody preparations and of fractions of antibody will allow us to 
decide between the mechanisms discussed above. 
In summary, we are led to the conclusions that early immune damage  is 
caused by two distinct reactions which differ in their time course, and of which 
only one involves the  complete hemolytic complement system, and  that  a 
heterogeneity of the antibody with respect to tissue fixation and/or interaction 
with  complement  is  responsible  for  the  occurrence  of  two  phases  of  the 
cutaneous response. 
Contradictory results, obtained by different investigators of the role of com- 
plement in immune damage, may be attributable to differences between differ- 
ent mammalian species,  and to variations in the same species in the concentra- 
tion of antibody fractions which differ in their ability to fix to tissues and to fix 
complement. Furthermore, difficulties  in separating the distinct but overlapping 
cutaneous reactions, demonstrated in the foregoing experiments, may result in 
apparently contradictory findings. 
SUxcM'~d~y 
Intradermal injection of mice with ribonuclease antibody, followed by intra- 
venous injection with ribonuclease, resulted in permeability increase, demon- 
strable by "blueing." The size of the blued area depends on the quantity of anti- 
body injected and on the interval between the two injections. If antigen was 
injected first and antibody was  injected subsequently, a  similar increase in 
permeability was observed in animals having a  complete complement system 
(MuBl-positive)  and in animals which have a  deficient complement system 
(MuBl-negative). Marked differences in response were observed between these 
two types of mice if antigen was injected some hours after the antibody. In 
MuBl-negative mice, a blueing reaction was not observed at intervals between 
injections (2~ hours if 3 #g N antibody and 15 hours if 25 #g N antibody were in- 
jected intradermally) at which MuBl-positive animals showed a marked perme- 
ability increase. At these intervals, blueing did occur in MuBl-negative animals 
if they were injected with the serum of MuBl-positive mice or with fresh guinea 
pig serum. Blueing was not induced if the serum of MuBl-negative mice or 
heated guinea pig serum was injected. The occurrence of two distinct phases of 
the  cutaneous reaction,  of which  only one involves the complete hemolytic 
complement system, was deduced from these observations. 
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